Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled trials and real-world studies.
| Author | |
|---|---|
| Abstract |
:
The question of whether the use of dabigatran etexilate is associated with a high risk of myocardial infarction (MI) remains unanswered owing to the lack of critical evidences. |
| Year of Publication |
:
2018
|
| Journal |
:
International journal of cardiology
|
| Volume |
:
267
|
| Number of Pages |
:
1-7
|
| Date Published |
:
2018
|
| ISSN Number |
:
0167-5273
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S0167-5273(18)30457-1
|
| DOI |
:
10.1016/j.ijcard.2018.05.048
|
| Short Title |
:
Int J Cardiol
|
| Download citation |
